Torrent Pharmaceuticals Share Price

NSE: TORNTPHARM

₹ 4,961.50

-₹103.70 (-2.05%)

Last updated 24 Jul, 2026, 15:49 IST

Torrent Pharmaceuticals Share Price Today

As of 25 Jul 2026, Torrent Pharmaceuticals share price is ₹4,961.50. The stock opened at ₹5,026.00, compared to its previous close of ₹5,065.20. During today's trading session, Torrent Pharmaceuticals share price moved in the range of ₹4,951.70 to ₹5,049.90, with an average price of ₹5,000.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,480.60 and a high of ₹5,085.80. On the performance front, Torrent Pharmaceuticals share price has increased by 26.18% over the last six months and is up 40.96% on a year-on-year basis.

₹4,951.70

2.05% down today

₹5,049.90

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 7.44% YoY

Latest Earning

Net Profit TrendUp by 11.88% YoY

Latest Earning

Revenue TrendUp by 27.05% QoQ

Stock Performance

OutperformingBeat Nifty by 13.37 % in last 1 month

Shareholding Pattern

PromoterPromoter decreased stake by 11.02%

Shareholding Pattern

DIIDII decreased stake by 5.99%

Shareholding Pattern

FIIFII increased stake by 16.42%

Torrent Pharmaceuticals Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹6,88,371+₹1,88,371 (+37.67%)

3 Year

₹12,38,610+₹7,38,610 (+147.72%)

5 Year

₹16,15,545+₹11,15,545 (+223.11%)

₹4,558.70₹5,571.70

Circuit Low

Circuit High

₹3,480.60₹5,085.80

52-Week Low

52-Week High

Circuit

₹4,558.70

₹5,571.70

52-week

₹3,480.60

₹5,085.80

Mkt Cap Cr

1,92,687.00

P/E

66.03

P/B

17.03

ROE

26.76%

D/E

1.05

ROCE

18.30%

Div. Yield

0.90%

EPS(TTM)

64.75

Turnover

0.49

EV/EBITDA

35.81

Net Margin

20.46%

Op. Margin

37.35%

ROA

6.46%

Quick Ratio

0.73

Curr. Ratio

0.98

Mkt Cap Cr

1,92,687.00

P/E

66.03

P/B

17.03

ROE

26.76%

D/E

1.05

ROCE

18.30%

Div. Yield

0.90%

EPS(TTM)

64.75

Turnover

0.49

EV/EBITDA

35.81

Net Margin

20.46%

Op. Margin

37.35%

ROA

6.46%

Quick Ratio

0.73

Curr. Ratio

0.98

Based on fundamentals, this stock's

Performance

Excellent

Torrent Pharma. outperforming all market indices

Valuation

Overvalued

Torrent Pharma. appears overvalued compared to its peers

Earnings

Good

Torrent Pharma. revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,65,711.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	97,364.90	30.58	2.56	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.40	16.70%	97.21	0.12%	0.64	13.72
Biocon	70,908.00	151.62	1.71	1.34%	0.10	3.76%	2.16	0.14%	0.09	0.27

Torrent Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹13,979.73	₹11,516.09	₹10,727.84	₹9,620.15
Other Income	-₹93.58	₹23.27	₹57.91	₹45.14
Total Revenue	₹13,886.15	₹11,539.36	₹10,785.75	₹9,665.29
Total Expenses	₹10,925.21	₹8,842.34	₹8,522.02	₹7,818.13
Profit Before Tax	₹2,872.19	₹2,672.81	₹2,352.11	₹1,847.16
Tax	₹734.01	₹761.56	₹695.73	₹601.93
Profit After Tax	₹2,138.18	₹1,911.25	₹1,656.38	₹1,245.23
EPS - Basic	₹63.92	₹56.47	₹48.94	₹36.79
EPS - Diluted	₹63.92	₹56.47	₹48.94	₹36.79

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹2,872.19	₹2,672.81	₹2,352.11	₹1,847.16
Income before WC changes	₹4,173.60	₹3,668.86	₹3,346.10	₹2,784.40
Change in Assets	-₹328.20	-₹296.98	₹22.11	-₹53.29
Change in Liabilities	-₹13.77	-₹183.95	₹395.97	₹35.09
Change in WC	-₹341.97	-₹480.93	₹418.08	-₹18.20
Cash flow from Operations	₹3,022.71	₹2,585.11	₹3,266.08	₹2,368.13
Cash flow from Investing	-₹12,712.41	-₹540.05	-₹167.90	-₹2,415.31
Cash flow from Financing	₹10,150.60	-₹2,297.99	-₹2,779.64	₹77.36
Total Cash Flow	₹460.90	-₹252.93	₹318.54	₹30.18
Cash (Start of the year)	₹573.48	₹835.14	₹508.53	₹398.40
Cash (End of the year)	₹1,117.20	₹573.48	₹835.14	₹508.53

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹34,920.07	₹9,367.17	₹9,449.10	₹9,698.13
Current Assets	₹9,391.89	₹5,622.57	₹5,611.48	₹5,313.72
Total Assets	₹44,311.96	₹14,989.74	₹15,060.58	₹15,011.85
Current Liabilities	₹8,343.33	₹4,717.19	₹5,425.25	₹5,447.30
Net Current Asset	₹1,048.56	₹905.38	₹186.23	-₹133.58
Non-Current Liabilities	₹18,383.80	₹2,681.86	₹2,779.18	₹3,366.48
Equity Capital	₹17,584.83	₹7,590.69	₹6,856.15	₹6,198.07
Total Equity & Liabilities	₹44,311.96	₹14,989.74	₹15,060.58	₹15,011.85

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹10,712.00	₹9,682.44	₹8,532.90	₹7,695.20
Other Income	₹17.92	₹31.50	₹91.36	₹81.88
Total Revenue	₹10,729.92	₹9,713.94	₹8,624.26	₹7,777.08
Total Expenses	₹7,763.29	₹7,079.55	₹6,707.69	₹6,200.06
Profit Before Tax	₹2,896.61	₹2,610.18	₹1,916.57	₹1,577.02
Tax	₹705.02	₹722.12	₹559.49	₹525.63
Profit After Tax	₹2,191.59	₹1,888.06	₹1,357.08	₹1,051.39
EPS - Basic	₹64.75	₹55.79	₹40.10	₹31.07
EPS - Diluted	₹64.75	₹55.79	₹40.10	₹31.07

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹2,896.61	₹2,610.18	₹1,916.57	₹1,577.02
Income before WC changes	₹3,912.76	₹3,579.68	₹2,874.18	₹2,567.51
Change in Assets	-₹466.77	-₹638.12	₹212.68	-₹51.24
Change in Liabilities	₹0.78	₹123.05	₹130.92	₹21.60
Change in WC	-₹465.99	-₹515.07	₹343.60	-₹29.64
Cash flow from Operations	₹2,730.83	₹2,574.50	₹2,893.10	₹2,265.41
Cash flow from Investing	-₹12,990.20	-₹470.09	-₹296.07	-₹2,384.07
Cash flow from Financing	₹10,225.23	-₹2,104.46	-₹2,577.57	₹80.74
Total Cash Flow	-₹34.14	-₹0.05	₹19.46	-₹37.92
Cash (Start of the year)	₹104.81	₹104.86	₹85.40	₹65.00
Cash (End of the year)	₹70.67	₹104.81	₹104.86	₹85.40

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹20,922.49	₹8,492.96	₹8,635.53	₹8,944.85
Current Assets	₹4,891.04	₹4,348.80	₹3,741.06	₹3,927.08
Total Assets	₹25,813.53	₹12,841.76	₹12,376.59	₹12,871.93
Current Liabilities	₹4,588.83	₹2,979.63	₹2,988.60	₹3,409.15
Net Current Asset	₹302.21	₹1,369.17	₹752.46	₹517.93
Non-Current Liabilities	₹12,772.53	₹2,269.63	₹2,559.23	₹3,006.82
Equity Capital	₹8,452.17	₹7,592.50	₹6,828.76	₹6,455.96
Total Equity & Liabilities	₹25,813.53	₹12,841.76	₹12,376.59	₹12,871.93

* All values are in INR Crore

Qty

Bid

4961.5

Ask

Qty

Bid Total: 31

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bearish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

67.43

Neutral

ATR (14)

143.85

Neutral

STOCH(9,6)

94.73

Bearish

STOCH RSI (14)

52.1

Neutral

ADX(9)

32.84

Bearish

UO(9)

67.25

Neutral

ROC(12)

4.29

Bullish

WillR(14)

-5.27

Bearish

Period

Simple value

Exponential vaue

4981.54

5015.17

10D

4973.92

4963.77

20D

4852.38

4862.09

50D

4608.34

4658.29

100D

4431.52

4470.62

About Torrent Pharmaceuticals

ISIN

INE685A01028

Sector Market Cap

₹ 1,92,687 Cr

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.

Torrent Pharmaceuticals Financial Highlights

Revenue: Torrent Pharmaceuticals reported revenue of ₹13,886.00 crore in FY26 vs ₹11,539.00 crore in FY25. It showed an increase of 20.34% on a yearly basis.
Operating Profit: Torrent Pharmaceuticals reported an operating profit of ₹2,872.00 crore in FY26 vs ₹2,673.00 crore in FY25. It showed an increase of 7.44% on a year-on-year basis.
Net Profit: Torrent Pharmaceuticals reported a net profit of ₹2,138.00 crore in FY26 vs ₹1,911.00 crore in FY25. It showed an increase of 11.88% on a yearly basis.

Torrent Pharmaceuticals Quarterly Result Highlights

Torrent Pharmaceuticals reported revenue of ₹4,180.00 crore in Mar 2026, compared with ₹3,290.00 crore in Dec 2025, representing an increase of 27.05% on a quarter-on-quarter (QoQ) basis.
Torrent Pharmaceuticals reported an operating profit of ₹529.00 crore in Mar 2026, compared with ₹814.00 crore in Dec 2025, representing a decrease of 35.01% on a quarter-on-quarter (QoQ) basis.
Torrent Pharmaceuticals reported a profit of ₹364.00 crore in Mar 2026, compared with ₹635.00 crore in Dec 2025, reflecting a decrease of 42.68% on a QoQ basis.
The earnings per share (EPS) of Torrent Pharmaceuticals stood at ₹63.92 during Mar 2026.